Promising Method For Early Diagnosis Of Cancer – Part 3 of 3
And as Cristofanilli muricate out, these plans so far are “only for research. The test is not available for clinical use”. According to the AP, four serious cancer centers – Mass General, Memorial Sloan-Kettering Cancer Center in New York City, the University of Texas’ MD Anderson Cancer Center in Houston, and the Dana-Farber Cancer Institute in Boston – will begin studies using the strange test this year. The test would need to be developed “along with the process of new drug development and new targeted therapies so we can better use the dope with a clinical purpose”.